Pruthi RS - Search Results

1

Neoadjuvant docetaxel/estramustine prior to radical prostatectomy or external beam radiotherapy in high risk localized prostate cancer: a phase II trial.

Kim WY, Whang YE, Pruthi RS, Baggstrom MQ, Rathmell WK, Rosenman JG, Wallen EM, Goyal LK, Grigson G, Watkins C, Godley PA. Kim WY, et al. Among authors: pruthi rs. Urol Oncol. 2011 Nov-Dec;29(6):608-13. doi: 10.1016/j.urolonc.2009.09.012. Epub 2009 Dec 21. Urol Oncol. 2011. PMID: 20022268 Clinical Trial.

2

Prostate-specific antigen.

Ornstein DK, Pruthi RS. Ornstein DK, et al. Among authors: pruthi rs. Expert Opin Pharmacother. 2000 Dec;1(7):1399-411. doi: 10.1517/14656566.1.7.1399. Expert Opin Pharmacother. 2000. PMID: 11249473 Review.

3

A pilot study of use of the cyclooxygenase-2 inhibitor celecoxib in recurrent prostate cancer after definitive radiation therapy or radical prostatectomy.

Pruthi RS, Derksen JE, Moore D. Pruthi RS, et al. BJU Int. 2004 Feb;93(3):275-8. doi: 10.1111/j.1464-410x.2004.04601.x. BJU Int. 2004. PMID: 14764122 Clinical Trial.

4

Comparison of clinical and pathological features in African-American and Caucasian patients with localized prostate cancer.

Kang JS, Maygarden SJ, Mohler JL, Pruthi RS. Kang JS, et al. Among authors: pruthi rs. BJU Int. 2004 Jun;93(9):1207-10. doi: 10.1111/j.1464-410X.2004.04846.x. BJU Int. 2004. PMID: 15180606

5

Partial nephrectomy with fibrin glue repair: measurement of vascular and pelvicaliceal hydrodynamic bond integrity in a live and abbatoir porcine model.

Kouba E, Tornehl C, Lavelle J, Wallen E, Pruthi RS. Kouba E, et al. Among authors: pruthi rs. J Urol. 2004 Jul;172(1):326-30. doi: 10.1097/01.ju.0000123823.27846.d7. J Urol. 2004. PMID: 15201805

6

Rationale for use of cyclooxygenase-2 inhibitors in prevention and treatment of bladder cancer.

Pruthi RS, Derksen E, Gaston K, Wallen EM. Pruthi RS, et al. Urology. 2004 Oct;64(4):637-42. doi: 10.1016/j.urology.2004.04.047. Urology. 2004. PMID: 15491687 Review. No abstract available.

7

Impact of race, age, income, and residence on prostate cancer knowledge, screening behavior, and health maintenance in siblings of patients with prostate cancer.

Pruthi RS, Tornehl C, Gaston K, Lee K, Moore D, Carson CC, Wallen EM. Pruthi RS, et al. Eur Urol. 2006 Jul;50(1):64-9. doi: 10.1016/j.eururo.2005.09.024. Epub 2005 Dec 12. Eur Urol. 2006. PMID: 16364537

8

Cyclooxygenase-2: a therapeutic target for prostate cancer.

Pruthi RS, Wallen EM. Pruthi RS, et al. Clin Genitourin Cancer. 2005 Dec;4(3):203-11. doi: 10.3816/CGC.2005.n.034. Clin Genitourin Cancer. 2005. PMID: 16425990 Review.

9

Large presacral schwannoma after radical prostatectomy.

Pruthi RS, Hubbard JS, Kouba E, Funkhouser W, Wallen E. Pruthi RS, et al. Eur Urol. 2006 May;49(5):914-7. doi: 10.1016/j.eururo.2006.01.057. Epub 2006 Feb 24. Eur Urol. 2006. PMID: 16524659

10

Phase II trial of celecoxib in prostate-specific antigen recurrent prostate cancer after definitive radiation therapy or radical prostatectomy.

Pruthi RS, Derksen JE, Moore D, Carson CC, Grigson G, Watkins C, Wallen E. Pruthi RS, et al. Clin Cancer Res. 2006 Apr 1;12(7 Pt 1):2172-7. doi: 10.1158/1078-0432.CCR-05-2067. Clin Cancer Res. 2006. PMID: 16609031 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

204 results

Search Page

Filters